Compare BLIN & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLIN | EVGN |
|---|---|---|
| Founded | 2000 | 1999 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | EDP Services | Agricultural Chemicals |
| Sector | Technology | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.1M | 11.1M |
| IPO Year | 2018 | 2013 |
| Metric | BLIN | EVGN |
|---|---|---|
| Price | $0.87 | $0.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $4.62 | $3.50 |
| AVG Volume (30 Days) | 28.8K | ★ 102.2K |
| Earning Date | 05-14-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,568,000.00 | N/A |
| Revenue This Year | $22.67 | N/A |
| Revenue Next Year | $21.08 | $73.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.69 | $0.37 |
| 52 Week High | $1.59 | $1.50 |
| Indicator | BLIN | EVGN |
|---|---|---|
| Relative Strength Index (RSI) | 26.04 | 44.60 |
| Support Level | $0.82 | $0.45 |
| Resistance Level | $0.87 | $0.86 |
| Average True Range (ATR) | 0.05 | 0.03 |
| MACD | -0.00 | -0.00 |
| Stochastic Oscillator | 5.77 | 48.85 |
Bridgeline Digital Inc is a AI-powered marketing technology company that offers a suite of products that help companies grow online revenue by driving more traffic to their websites, converting more visitors to purchasers, and increasing average order value. Company software is available through a cloud-based Software as a Service (SaaS) model. It helps to maximize the performance of critical websites, intranets, and online stores. The company generates revenue from digital engagement services, subscription, perpetual licenses, maintenance, and hosting. Geographically, it derives a majority of revenue from the United States.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.